Metabolic and appetite hormone responses of hyperinsulinemic normoglycemic males to meals with varied macronutrient compositions

Annals of Nutrition and Metabolism

Volumn 57, Issue 1, 2010, Pages 59-67

  El Khoury, Dalia ^a   Hwalla, Nahla ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Carbohydrates; Fats; Ghrelin; Hyperinsulinemia; Peptide YY; Proteins

Indexed keywords

GHRELIN; GLUCOSE; INSULIN; PEPTIDE YY [3-36]; TRIACYLGLYCEROL;

ADULT; APPETITE; ARTICLE; BLOOD SAMPLING; CARBOHYDRATE DIET; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HORMONE RESPONSE; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; LIPID DIET; MACRONUTRIENT; MALE; METABOLISM; PRIORITY JOURNAL; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; APPETITE REGULATION; BLOOD GLUCOSE; DIETARY CARBOHYDRATES; DIETARY FATS; DIETARY PROTEINS; GHRELIN; HUMANS; HYPERINSULINISM; INSULIN; MALE; OBESITY; PEPTIDE YY; POSTPRANDIAL PERIOD; TRIGLYCERIDES; YOUNG ADULT;

EID: 77955536126     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000317343     Document Type: Article

References (49)

1. Liu J, da Silva AA, Tallam LS, Hall JE: Chronic central nervous system hyperinsulinemia and regulation of arterial pressure and food intake. J Hypertens 2006; 24: 1391-1395.
2. Anthony K, Reed LJ, Dunn JT, Bingham E, Hopkins D, Marsden PK, Amiel SA: Attenuation of insulin-evoked responses in brain networks controlling appetite and reward in insulin resistance: the cerebral basis for impaired control of food intake in metabolic syndrome? Diabetes 2006; 55:2986-2992.
3. McLaughlin T, Abbasi F, Lamendola C, Frayo RS, Cummings DE: Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls. J Clin Endocrinol Metab 2004; 89:1630-1635.
4. Boey D, Heilbronn L, Sainsbury A, Laybutt R, Kriketos A, Herzog H, Campbell LV: Low serum PYY is linked to insulin resistance in first-degree relatives of subjects with type 2 diabetes. Neuropeptides 2006; 40:317-324.
5. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR: Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001; 86:5992-5995.
6. Cummings DE, Shannon MH: Roles for ghrelin in the regulation of appetite and body weight. Arch Surg 2003; 138: 389-396.
7. Pöykkö SM, Kellokoski E, Hörkkö S, Kauma H, Kesäniemi YA, Ukkola O: Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 2003; 52:2546-2553.
8. Adrian TE, Ferri GL, Bacarese-Hamilton AJ, Fuessl HS, Polak JM, Bloom SR: Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 1985; 89:1070-1077.
9. Grandt D, Schimiczek M, Beglinger C, Layer P, Goebell H, Eysselein VE, Reeve JR Jr: Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36. Regu l Pept 1994; 51: 151-159.
10. Chan JL, Stoyneva V, Kelesidis T, Raciti P, Mantzoros CS: Peptide YY levels are decreased by fasting and elevated following caloric intake but are not regulated by leptin. Diabetologia 2006; 49: 169-173.
11. 3-36. N Engl J Med 2003; 349: 941-948.
12. Torekov SS, Larsen LH, Glumer C, Borch-Johnsen K, Jorgensen T, Holst JJ, Madsen OD, Hansen T, Pedersen O: Evidence of an association between the Arg72 allele of the peptide YY and increased risk of type 2 diabetes. Diabetes 2005; 54:2261-2265.
13. Viardot A, Heilbronn LK, Herzog H, Gre-gersen S, Campbell LV: Abnormal postprandial PYY response in insulin sensitive non-diabetic subjects with a strong family history of type 2 diabetes. Int J Obes (Lond) 2008; 32: 943-948.
14. Boey D, Lin S, Karl T, Baldock P, Lee N, En-riquez R, Couzens M, Slack K, Dallmann R, Sainsbury A, Herzog H: Peptide YY ablation in mice leads to the development of hyperin-sulinaemia and obesity. Diabetologia 2006; 49:1360-1370.
15. Keogh JB, Luscombe-Marsh ND, Noakes M, Wittert GA, Clifton PM: Long-term weight maintenance and cardiovascular risk factors are not different following weight loss on carbohydrate-restricted diets high in either monounsaturated fat or protein in obese hy-perinsulinaemic men and women. Br J Nutr 2007; 97:405-410.
16. Purnell JQ, Brunzell JD: The central role of dietary fat, not carbohydrate, in the insulin resistance syndrome. Curr Opin Lipidol 1997; 8:17-22.
17. Baba NH, Sawaya S, Torbay N, Habbal Z, Azar S, Hashim SA: High protein vs high carbohydrate hypoenergetic diet for the treatment of obese hyperinsulinemic subjects. Int J Obes Relat Metab Disord 1999; 23: 1202-1206.
18. Torbay N, Hwalla NB, Sawaya S, Bajjani R, Habbal Z, Azar S, Hashim SA: High protein vs high carbohydrate hypoenergetic diet in treatment of obese normoinsulinemic and hyperinsulinemic subjects. Nutr Res 2002; 22: 587-598.
19. Chandalia M, Garg A, Lutjohann D, von Bergmann K, Grundy SM, Brinkley LJ: Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus. N Engl J Med 2000; 342: 1392-1398.
20. Schulze MB, Hu FB: Dietary approaches to prevent the metabolic syndrome: quality versus quantity of carbohydrates. Diabetes Care 2004; 27:613-614.
21. Reaven G M : Dohighcarbo hydrate diets prevent the development or attenuate the manifestations (or both) of syndrome X? A viewpoint strongly against. Curr Opin Lipidol 1997; 8: 23-27.
22. Erdmann J, Mayr M, Oppel U, Sypchenko O, Wagenpfeil S, Schusdziarra V: Weight-dependent differential contribution of insulin secretion and clearance to hyperinsulinemia of obesity. Regul Pept 2009; 152:1-7.
23. Stubbs RJ: Nutrition Society Medal Lecture: appetite feeding behaviour and energy balance in human subjects. Proc Nutr Soc 1998; 57: 341-356.
24. Tome D: Protein, amino acids and the control of food inta ke. Br J Nutr 2004; 92:S27-S30.
25. Eisenstein J, Roberts SB, Dallal G, Saltzman E: High-protein weight-loss diets: are they safe and do they work? A review of the experimental and epidemiologic data. Nutr Rev 2002; 60: 189-200.
26. Layman DK, Clifton P, Gannon MC, Krauss RM, Nuttall FQ: Protein in optimal health: heart disease and type 2 diabetes. Am J Clin Nutr 2008; 87: 1571S-1575S.
27. Tannousdit El Khoury D, Obeid O, Azar S, Hwalla N: Variations in postprandial ghrel in status following ingestion of high-carbohydrate, high-fat, and high-protein meals in males. Ann Nutr Metab 2006; 50: 260-269.
28. Batterham RL, Heffron H, Kapoor S, Chivers JE, Chandarana K, Herzog H, Le Roux CW, Thomas EL, Bell JD, Withers DJ: Critical role for peptide YY in protein-mediated satiation and body-weight regulation. Cell Metab 2006; 4: 223-233.
29. Leonetti F, Iacobellis G, Ribaudo MC, Zap-paterreno A, Tiberti C, Iannucci CV, Vecci E, Di Mario U: Acute insulin infusion decreases plasma ghrelin levels in uncomplicated obesity. Regul Pept 2004; 122:179-183.
30. Weigle DS, Cummings DE, Newby PD, Breen PA, Frayo RS, Matthys CC, Callahan HS, Purnell JQ: Roles of leptin and ghrelin in the loss of body weight caused by a low fat, high carbohydrate diet. J Clin Endocrinol Metab 2003; 88:1577-1586.
31. Monteleone P, Bencivenga R, Longobardi N, Serritella C, Maj M: Differential responses of circulating ghrelin to high-fat or high-carbohydrate meal in healthy women. J Clin En-docrinol Metab 2003; 88:5510-5514.
32. A lawar R, Obeid OA, Hwalla N, Azar S: Postprandial acylated ghrelin status following fat and protein manipu lation of meals in hea lthy young women. Clin Sci (Lond) 2005; 109: 405-411.
33. Nilsson M, Stenberg M, Frid AH, Holst JJ, Björck IM: Glycemia and insulinemia in healthy subjects after lactose-equivalent meals of milk and other food proteins: the role of plasma amino acids and incretins. Am J Clin Nutr 2004; 80:1246-1253.
34. Greenman Y, Golani N, Gilad S, Yaron M, Limor R, Stern N: Ghrelin secretion is modulated in a nutrient-and gender-specific manner. Clin Endocrinol (Oxf) 2004; 60:382-388.
35. Zwirska-Korczala K, Konturek SJ, Sodowski M, Wylezol M, Kuka D, Sowa P, Adamczyk-Sowa M, Kukla M, Berdowska A, Rehfeld JF, Bielanski W, Brzozowski T: Basal and postprandial plasma levels of PPY, ghrelin, cho-lecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome. J Physiol Pharmacol 2007; 58: 13-35.
36. Barber TM, Casanueva FF, Karpe F, Lage M, Franks S, McCarthy MI, Wass JA: Ghrelin levels are suppressed and show a blunted response to oral glucose in women with poly-cystic ovary syndrome. Eur J Endocrinol 2008; 158: 511-516.
37. Moran LJ, Noakes M, Clifton PM, Wittert GA, Tomlinson L, Galletly C, Luscombe ND, Norman RJ: Ghrelin and measures of satiety are altered in polycystic ovary syndrome but not differentially affected by diet composition. J Clin Endocrinol Metab 2004; 89:3337-3344.
38. Bacha F, Arslanian SA: Ghrelin suppression in overweight children: a manifestation of insulin resistance? J Clin Endocrinol Metab 2005; 90:2725-2730.
39. Marzullo P, Verti B, Savia G, Walker GE, Guzzaloni G, Tagliaferri M, Di Blasio A, Liuzzi A: The relationship between active ghrelin levels and human obesity involves alterations in resting energy expenditure. J Clin Endocrinol Metab 2004; 89:936-939.
40. Essah PA, Levy JR, Sistrun SN, Kelly SM, Nestler JE: Effect of macronutrient composition on postprandial peptide YY levels. J Clin Endocrinol Metab 2007; 92:4052-4055.
41. Viardot A, Heilbronn LK, Herzog H, Gre-gersen S, Campbell LV: Abnormal postprandial PYY response in insulin sensitive non-diabetic subjects with a strong family history of type 2 diabetes. Int J Obes (Lond) 2008; 32: 943-948.
42. Brand-Miller JC, Colagiuri S, Gan ST: Insulin sensitivity predicts glycemia after a protein load. Metabolism 2000; 49:1-5.
43. Hwalla N, Shaker L, Torbay N, Azar S T, Habbal Z, Adra N: Postprandial glycemic and in-sulinemic responses to high-carbohydrate vs high-protein meals in obese normoglycemic subjects with varied insulin sensitivity. Nutr Res 2005; 25: 535-548.
44. Ceriello A, Bortolotti N, Motz E, Crescentini A, Lizzio S, Russo A, Tonutti L, Taboga C: Meal-generated oxidative stress in type 2 diabetic patients. Diabetes Care 1998; 21:1529-1533.
45. Shishehbor F, Roche HM, Gibney MJ: The effect of low and moderate fat intakes on the postprandial lipaemic and hormonal responses in healthy volunteers. Br J Nutr 1999; 81 : 25-30.
46. Gaenzer H, Sturm W, Neumayr G, Kirch-mair R, Ebenbichler C, Ritsch A, Föger B, Weiss G, Patsch JR: Pronounced postprandial lipemia impairs endothelium-depen-dent dilation of the brachial artery in men. Cardiovasc Res 2001; 52:509-516.
47. Stone NJ: Secondary causes of hyperlipid-emia. Med Clin North Am 1994; 78:117-141.
48. Boivin M, Lanspa SJ, Zinsmeister AR, Go VL, DiMagno EP: Are diets associated with different rates of human interdigestive and postprandial pancreatic enzyme secretion? Gastroenterology 1990; 99: 1763-1771.
49. De Schepper H, Camilleri M, Cremonini F, Foxx-Orenstein A, Burton D: Comparison of gastric volumes in response to isocaloric liquid and mixed meals in humans. Neurogas-troenterol Motil 2004; 16 : 567-573.